The company is a high-tech enterprise based on the regenerative medicine industry, expanding fields related to life and health, and grafting the world's high-end technical resources and achievements. It continues to lay out in biomaterials, stem cells, pharmaceuticals, and advanced medical technology and product business fields. The core business forms a “3+1” pattern, namely the three major business segments of materials, cells, and pharmaceuticals, and a technology incubation platform. The company's main business is the production and sale of medical devices, pharmaceuticals, and the provision of cell technology services. The main products include biotype dural (spine) membrane patches, B-type cerebral (spine) membrane patches, thoracic surgical repair films, sterile biological wound protection films, Ario breast patches, benverimod cream, cell storage, cellular cartilage therapy, etc. Corporate honors: 2008 China's top ten most valuable enterprises, two high and six new enterprises; 2008 China's top 30 enterprises with the most investment value; 2009 China's top 50 most valuable investment enterprises, etc., and won the “Charitable and Caring Enterprise” award issued by the Guangzhou Huangpu District Social Construction Promotion Association.
No Data